In ASCVD, moderate-intensity statin + ezetimibe was noninferior to high-intensity statin alone at 3 y.

Journal Article (Journal Article)

Kim BK, Hong SJ, Lee YJ, et al. Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial. Lancet. 202;400:380-90. 35863366.

Full Text

Duke Authors

Cited Authors

  • Kelsey, MD; Newby, LK

Published Date

  • November 2022

Published In

Volume / Issue

  • 175 / 11

Start / End Page

  • JC126 -

PubMed ID

  • 36315955

Electronic International Standard Serial Number (EISSN)

  • 1539-3704

Digital Object Identifier (DOI)

  • 10.7326/J22-0085


  • eng

Conference Location

  • United States